HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

Clinical trial NCT05787535 · UNKNOWN

Trial details

NCT number: NCT05787535
Sponsor: HRYZ Biotech Co.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer Head and Neck Squamous Cell Carcinoma Oropharyngeal Cancer Vagina Tumor Carcinoma of Penis Anal Carcinoma Carcinoma of Vulva

Start date: 2023-03-21
Primary completion: 2025-02-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.